Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors

Overview of attention for article published in Investigational New Drugs, April 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 363 followers.

[NRP] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.: ... http://t.co/eIs8Ge8YRP [PM]

Reply Repost Favourite